July 9, 2010

Illinois Nursing Homes Owners Involved in Illegal Pharmaceutical Sales

A new lawsuit filed in Illinois this week alleges illegal kickbacks in a sale of a Chicago-based pharmaceutical company owned by the operators of Illinois nursing homes, reports the Chicago Tribune. The suit charges pharmaceutical giant Omnicare, Inc. with paying kickbacks in its purchase of Chicago based company Total Pharmacy. Total Pharmacy is owned by Chicago nursing home operators Phillip and Morris Esformes.

The lawsuit was filed by two whistleblowers, Maureen Nehls and Adam Resnik, both former employees and consultants for Total Pharmacy.

Nehls and Resnik described the details of the illegal activity, explaining how Omnicare agreed to pay more money (ultimately $25 million) to buy Total Pharmacy, so long as they also received guaranteed contracts to provide medical drugs to many of the nursing homes owned by the Esformeses. In addition, the Esformeses were allowed to keep an additional $7 million in accounts receivable, a hidden payment to avoid taxes and inflate the actual value of the sale for the Esformeses.

Federal anti-kickback law forbid pharmacies from paying nursing home owners to induce them to buy Medicare and Medicaid funded medicine for residents. The logic behind the law is simple: Nursing home owners should not personally gain at the taxpayers’ expense and nursing home residents should not be pawns in an attempt at personal enrichment for nursing home owners.

However, the Esformeses have shown that making money out of their nursing homes matters more than the care of the residents for whom they are responsible. The claims in this kickback lawsuit are merely the latest in a series of elder abuse and nursing home negligence at the Esformes-run Chicago nursing homes.

Among the Esformeses many Chicago nursing homes are Presidential Pavilion at 80th and Western and Burnham Healthcare in the south suburbs. Several of the 28 homes owed by the father-son team have been subjects of state and federal investigations for providing inadequate treatment. In one of those investigations, the Esformeses instigated a patient-brokering scheme, where residents were brought to local psychiatry hospitals to receive treatment, even when the patient did not have any need for such treatment. In other words, nursing home resident were used as pawns all to allow the nursing home operators to make more money.

These appalling acts committed by nursing home operators highlight the perilous situation of many vulnerable nursing home residents. The only way to ensure that these forms of elder abuse are eliminated is to provide close oversight of all owners and operators of our nursing homes.

Our Chicago nursing home lawyers at Levin & Perconti have spent years putting the magnifying glass on illegal, inadequate, and improper activity at Chicago nursing homes. If you suspect any such treatment at a facility, please contact our office so we can help put our considerable resources behind the uncovering the abuse. No elderly resident should have to sacrifice their health and well-being because greedy owners want to fill their wallet. Contact our office today.

August 1, 2007

Hip pad study comes with conflict of interest

A recent study published by the Journal of the American Medical Association reported that hip protectors did not provide any substantial reduction in the incidence of hip fractures. However, the authors of the study failed to disclose that they receive research funding from the manufacturers of bone-strengthening drugs. The JAMA defends itself, claiming that it cannot possibly investigate the financial sources of all of its authors, and experts on integrity and ethics in research believe that such failures to disclose are typically innocent. However, others believe that the study could easily be interpreted to discontinue the use of hip protectors in favor of the products of the authors’ corporate backers.

Continue reading "Hip pad study comes with conflict of interest" »

March 8, 2007

Former nursing home director must reimburse state $4000 for receiving illegal kickbacks

A former New Jersey nursing home director was ordered by a judge to reimburse $4,320 she received in exchange for swaying residents to use a particular pharmacy. In October, the former nursing home director pleaded guilty to 4th degree theft for her nursing home abuse. Between January 2000 and February 2002, the former director accepted cash kickbacks from the pharmacy owner for directing residents to exclusively fill prescriptions at his location. The pharmacy owner was sentenced to 7 years in prison and ordered to pay $1.1 million in restitution.

For the full article.

February 10, 2007

Chamber of Commerce President faces conflict-of-interest investigation

As president of the U.S. Chamber of Commerce, he has long been “hard” on federal regulation, but now he faces it personally. For 12 years, he has been a board member of Sunrise Senior Living, a living facility designed for Senior Citizens. Sunrise Senior Living is a publicly traded company being probed by the Securities and Exchange Commission (SEC). Sunrise co-founder started as the Chamber of Commerce president’s driver while still in college and later became a Chamber speechwriter. Recently, the SEC began in inquiry into an allegation that this president and other insiders may have improperly cashed $32 million in stock options before Sunrise in May announced an accounting problem that caused its stock to drop.

For the full article.

January 23, 2007

Revised ethics requirements bars drug firms from giving gifts to docs

Pharmaceutical companies that belong to the International Federation of Pharmaceutical Manufacturers & Assns. must adhere to a newly revised code of ethics. Among the requirements, pharmaceutical companies are forbidden from giving docs money or other gifts that might influence drug choices, such as paying for trips to golf resorts or luxury hotels. The ethics code had not been update in a decade and now applies to 26 member companies, including Pfizer.

For the full article.

December 12, 2006

Leading government Alzheimer’s researcher charged with criminal conflict of interest

Last week, federal prosecutors charged a leading government Alzheimer’s researcher with engaging in a criminal conflict of interest. The researcher, working for the National Institute of Health (NIH), had earned $285,000 in private consulting fees from a pharmaceutical giant. The researcher stands accused of performing consulting work for Pfizer Inc. that improperly overlapped with his government duties.

This charge comes after the government announced tougher ethical restrictions on NIH researchers to avoid such conflicts of interest where employees were making significant money from consulting with pharmaceutical firms. If convicted, this researcher faces a maximum of 1 year in prison and a $100,000 fine.

For the full article.